RA Capital, RTW Investments, Janus Henderson Investors are pouring another $175 million into a radiopharmaceuticals startup.

Ar­bor Biotech­nolo­gies is trim­ming its ear­ly-stage dis­cov­ery work, lead­ing to lay­offs in the group.

Key players include SynBioBeta, Arbor Biotechnologies, DNA Script, and Creative Biogene. PCR and real-time PCR assays are crucial tools for research and development. The market is vast ...

A 19-year-old man was assaulted in Ann Arbor just before 1 a.m. Sept. 15 after he was asked by a group of men if he was Jewish, and he confirmed he was. The 7-month-old kitten who the humane ...

After hours: September 27 at 7:55 PM EDT ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...